Fifty examples of a distinctive clinicopathologic entity occurred in 49 patients who ranged in age from 8 to 70 (median 46) years. Forty-nine tumors were on the face, mainly the cheek, chin and forehead; most were present one to five years, and 85% of the patients were female. The growths varied in size from 3 to 8 mm; many were hard and annular, with a raised border and depressed nonulcerated center. Histologically, narrow strands of basaloid cells and epidermoid cyts infiltrated a fibrotic stroma. This tumor, which we have named desmoplastic trichoepithelioma, must be differentiated histologically from morphealike basal cell carcinoma, desmoplastic cutaneous metastasis, and certain benign adnexal neoplasms.
Immunohistochemical and ultrastructural observations of desmoplastic trichoepithelioma with a special reference to a morphological comparison with normal apocrine acrosyringeum
Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma
Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma
Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients
Benign cutaneous adnexal tumors in childhood and young adults, excluding pilomatrixoma: review of 28 cases and literature
Merkel cells are integral constituents of desmoplastic trichoepithelioma: an immunohistochemical and electron microscopic study
Benign hair-follicle derived tumours in the differential diagnosis of basal-cell carcinoma of the eyelids: a clinicopathological comparison
Desmoplastic trichoepithelioma: A clinicopathological study of three cases and a review of the literature
Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma
Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation
Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?
Guidelines of care for nevi. II. Nonmelanocytic nevi, hamartomas, neoplasms, and potentially malignant lesions. Committee on Guidelines of Care
Microcystic adnexal carcinoma: a case report with immunohistochemical and electron microscopical examinations
The value of carcinoembryonic antigen in differentiating sclerosing epithelial hamartoma from syringoma
Desmoplastic trichoepithelioma: clinico-pathological features and immunohistochemical study of the basement membrane proteins, laminin and type IV collagen
Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal Tumors
Basal cell carcinoma or not? Histological variants and mimics of the most common cutaneous malignancy
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma
Carcinoma, Basal Cell
Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.